CIK: 0001832749 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $112,679 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | PROMETHEUS BIOSCIENCES INC | 1,848,024 | $73,071 | 64.8% | $18.26 | — | COM | 74349U108 |
| — | PRAXIS PRECISION MEDICINES I | 988,995 | $19,483 | 17.3% | $55.02 | — | COM | 74006W108 |
| TRDA | ENTRADA THERAPTEUTICS INC | 509,024 | $8,714 | 7.7% | $17.12 | — | COM | 29384C108 |
| CRBU | CARIBOU BIOSCIENCES INC | 474,067 | $7,154 | 6.3% | $24.45 | -20.4% | COM | 142038108 |
| — | OMEGA THERAPEUTICS INC | 352,941 | $3,999 | 3.5% | $18.85 | — | COMMON STOCK | 68217N105 |
| — | WEWORK INC | 29,978 | $258 | 0.2% | $8.61 | — | CL A | 96209A104 |